Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1992-12-28
1994-07-12
Stoll, Robert L.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
424450, A61K 4300, A61K 9133
Patent
active
053286782
ABSTRACT:
Liposomes with hyperosmotic concentration of compounds encapsulated therein are targeted to tumors for neutron capture therapy. The compounds have an element with a large neutron capture cross section and an isotope that emits alpha particles when bombarded with neutrons. A method employing such liposomes for neutron capture therapy is also described.
REFERENCES:
patent: 4086330 (1978-04-01), Petkau et al.
patent: 4399817 (1983-08-01), Benedict
patent: 4466952 (1984-08-01), Hadd
patent: 4588578 (1986-05-01), Fountain et al.
patent: 4674480 (1987-06-01), Lemelson
patent: 5019369 (1991-05-01), Presant et al.
Goldenburg, D. M. et al., Neutron-capture therapy of human cancer . . . , PNAS, 81:560-63 (1984).
Hatanaka et al., "A Revised Boron-Neutron Capture Therapy", Z. Neurol, 204, (1973), pp. 309-332.
Fujii Gary
Gamble Ronald C.
Schmidt Paul G.
Covert John M.
Stoll Robert L.
Vestar, Inc.
LandOfFree
Composition and method of use for liposome encapsulated compound does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and method of use for liposome encapsulated compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method of use for liposome encapsulated compound will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-394525